Julie Royle chats with Iain Armstrong, chair of PHA UK, about IV and nebulised therapy, and compares the two for anyone who has a decision to make. She is joined by partner Kevin.
We are appreciative to Actelion Pharmaceuticals UK Ltd for an unrestricted grant to support the structure of this website. Actelion Pharmaceuticals Ltd have had no input into the contents of the website, which remains copyright to the PHA UK.